Mosaic ImmunoEngineering (CPMV) Stock Price, News & Analysis

Company Overview

Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.

Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development. While detailed pipeline disclosures remain limited, the company highlights its platform’s flexibility to deliver protein antigens in a highly multivalent format, potentially improving efficacy over traditional formulations. Though still early in its corporate history, Mosaic ImmunoEngineering’s approach reflects growing interest in novel nanoparticle-based vaccine technologies, with the company positioning itself to explore collaborations or licensing arrangements as its candidates advance.

Key Stats

• Today's Range: $0.79 to $0.79
• 50-Day Range: $0.36 to $0.90
• 52-Week Range: $0.25 to $1.00
• Volume: 8 shs
• Average Volume: 456 shs
• Market Capitalization: $5.74 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CPMV Stock Analysis - Frequently Asked Questions

How have CPMV shares performed this year?

Mosaic ImmunoEngineering's stock was trading at $0.7012 at the start of the year. Since then, CPMV shares have increased by 13.1% and is now trading at $0.7930.

How were Mosaic ImmunoEngineering's earnings last quarter?

Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) posted its earnings results on Tuesday, August, 19th. The company reported ($0.02) earnings per share for the quarter.

How do I buy shares of Mosaic ImmunoEngineering?

Shares of CPMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Mosaic ImmunoEngineering own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Mosaic ImmunoEngineering investors own include BioNxt Solutions (BNXTF), Defense Metals (DFMTF), C3.ai (AI), Applied Genetic Technologies (AGTC), Agile Therapeutics (AGRX), AgriFORCE Growing Systems (AGRI) and

Company Calendar

• Last Earnings: 8/19/2025
• Today: 9/09/2025
• Next Earnings (Estimated): 11/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CPMV
• CIK: 836564
• Web: www.ptsc.com
• Phone: (657) 208-0890
• Fax: 760-547-2705
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.10)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$920 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -822.45%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.94) per share
• Price / Book: -0.84

Miscellaneous

• Outstanding Shares: 7,240,000
• Free Float: 1,377,000
• Market Cap: $5.74 million
• Optionable: Not Optionable
• Beta: -1.20